Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury (English, HTML)
Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury: English HTML file. From Health Canada, updated May 2024. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2024-05-10
Health Canada reviewed the potential risk of liver injury with Pradaxa after receiving reports of severe liver injury from the manufacturer. The manufacturer was asked to provide all available data on Pradaxa and the risk of liver injury.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file